Compile Data Set for Download or QSAR
maximum 50k data
Found 153 Enz. Inhib. hit(s) with all data for entry = 11812
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649721(3-fluoro-2-hydroxy-5-(1-(4- (trifluoromethyl)pheny...)
Affinity DataIC50:  100nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649750(2-fluoro-6- ((morpholinoimino)methyl)-4- (3-(4-(py...)
Affinity DataIC50:  140nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649763(8-fluoro-4-hydroxy-3-(2- methoxyethyl)-6-(3-(4- (p...)
Affinity DataIC50:  200nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649697(3-fluoro-5-formyl-4-hydroxy- N-(5-phenylthiazol-2-...)
Affinity DataIC50:  200nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649705(3-fluoro-5-formyl-4-hydroxy- N-(5-(3-(pyrrolidin-1...)
Affinity DataIC50:  200nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649748((3-fluoro-4-hydroxy-5- ((morpholinoimino)methyl) p...)
Affinity DataIC50:  260nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649747((3-fluoro-4-hydroxy-5-(((4- methylpiperazin-1- yl)...)
Affinity DataIC50:  260nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649759(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50:  300nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649710(3-fluoro-5-formyl-4-hydroxy- N-(6-(pyrrolidin-1-yl...)
Affinity DataIC50:  300nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649723(5-hydroxy-2-(2-(6-(pyrrolidin- 1-yl)pyridin-3-yl)t...)
Affinity DataIC50:  400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649747((3-fluoro-4-hydroxy-5-(((4- methylpiperazin-1- yl)...)
Affinity DataIC50:  400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649704(3-fluoro-N-(5-(4- fluorophenyl)thiazol-2-yl)-5- fo...)
Affinity DataIC50:  400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649710(3-fluoro-5-formyl-4-hydroxy- N-(6-(pyrrolidin-1-yl...)
Affinity DataIC50:  400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649711(3-fluoro-2-hydroxy-5-(4-(4- (pyrrolidin-1- yl)phen...)
Affinity DataIC50:  400nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649749((E)-2-fluoro-6-(((4- methylpiperazin-1- yl)imino)m...)
Affinity DataIC50:  410nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649762(8-fluoro-4-hydroxy-3-methyl- 6-(3-(4-(pyrrolidin-1...)
Affinity DataIC50:  430nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649721(3-fluoro-2-hydroxy-5-(1-(4- (trifluoromethyl)pheny...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649721(3-fluoro-2-hydroxy-5-(1-(4- (trifluoromethyl)pheny...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649748((3-fluoro-4-hydroxy-5- ((morpholinoimino)methyl) p...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649751(3-fluoro-5-formyl-4-hydroxy- N-(3-(4-(pyrrolidin-1...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649756(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649757(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649695(3-fluoro-5-formyl-4-hydroxy- N-(5-phenyl-1,3,4-thi...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649697(3-fluoro-5-formyl-4-hydroxy- N-(5-phenylthiazol-2-...)
Affinity DataIC50:  500nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649747((3-fluoro-4-hydroxy-5-(((4- methylpiperazin-1- yl)...)
Affinity DataIC50:  600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649751(3-fluoro-5-formyl-4-hydroxy- N-(3-(4-(pyrrolidin-1...)
Affinity DataIC50:  600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649758(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50:  600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649760(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50:  600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649761(2-(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phe...)
Affinity DataIC50:  600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649705(3-fluoro-5-formyl-4-hydroxy- N-(5-(3-(pyrrolidin-1...)
Affinity DataIC50:  600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649705(3-fluoro-5-formyl-4-hydroxy- N-(5-(3-(pyrrolidin-1...)
Affinity DataIC50:  600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649710(3-fluoro-5-formyl-4-hydroxy- N-(6-(pyrrolidin-1-yl...)
Affinity DataIC50:  600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649719(3-fluoro-5-formyl-4-hydroxy- N-(5-(4- (trifluorome...)
Affinity DataIC50:  600nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649722(2-hydroxy-3-methoxy-5-(1-(4- (trifluoromethyl)phen...)
Affinity DataIC50:  700nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649723(5-hydroxy-2-(2-(6-(pyrrolidin- 1-yl)pyridin-3-yl)t...)
Affinity DataIC50:  700nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649704(3-fluoro-N-(5-(4- fluorophenyl)thiazol-2-yl)-5- fo...)
Affinity DataIC50:  700nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649722(2-hydroxy-3-methoxy-5-(1-(4- (trifluoromethyl)phen...)
Affinity DataIC50:  800nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649724(3-fluoro-2-hydroxy-5-(3-(6- (pyrrolidin-1-yl)pyrid...)
Affinity DataIC50:  800nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649763(8-fluoro-4-hydroxy-3-(2- methoxyethyl)-6-(3-(4- (p...)
Affinity DataIC50:  800nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649749((E)-2-fluoro-6-(((4- methylpiperazin-1- yl)imino)m...)
Affinity DataIC50:  900nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649757(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50:  900nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649697(3-fluoro-5-formyl-4-hydroxy- N-(5-phenylthiazol-2-...)
Affinity DataIC50:  900nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649703(N-(3-fluoro-5-formyl-4- hydroxyphenyl)-5- phenylth...)
Affinity DataIC50:  900nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649708(3-fluoro-5-formyl-4-hydroxy- N-(2-phenyloxazol-4- ...)
Affinity DataIC50:  900nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649711(3-fluoro-2-hydroxy-5-(4-(4- (pyrrolidin-1- yl)phen...)
Affinity DataIC50:  900nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649750(2-fluoro-6- ((morpholinoimino)methyl)-4- (3-(4-(py...)
Affinity DataIC50:  1.00E+3nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649756(2-fluoro-6-formyl-4-(3-(4- (pyrrolidin-1-yl)phenyl...)
Affinity DataIC50:  1.00E+3nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 9(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649703(N-(3-fluoro-5-formyl-4- hydroxyphenyl)-5- phenylth...)
Affinity DataIC50:  1.00E+3nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 2(Homo sapiens (Human))
Neuropore Therapies

US Patent
LigandPNGBDBM649704(3-fluoro-N-(5-(4- fluorophenyl)thiazol-2-yl)-5- fo...)
Affinity DataIC50:  1.00E+3nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetToll-like receptor 6(Homo sapiens)
Neuropore Therapies

US Patent
LigandPNGBDBM649706(3-fluoro-5-formyl-4-hydroxy- N-(5-(4-(pyrrolidin-1...)
Affinity DataIC50:  1.00E+3nMAssay Description:On day 1, 50 μL of each test compound dilution in duplicates or a vehicle control was added to each well of a 96-well plate followed by addition...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 153 total ) | Next | Last >>
Jump to: